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INTRODUCTION
In normal pregnancy, placenta undergoes vascu-
larization to allow adequate circulation between
mother and her fetus. This vascularization consists
of extensive vasculogenesis and angiogenesis. An-
giogenesis is a process of neovascularization out of
the preexisting blood vessels, while vasculogenesis
is a process of forming new vessels. Placental per-
fusion depends on the angiogenesis, which is re-
sponsible in increasing placental blood flow in
pregnancy.1 Disruption in normal placental forma-
tion due to disorder of trophoblastic invasion has
been pointing to incidence of preeclampsia. On the
other hand, the trophoblastic uncontrolled inva-
sion and abnormal growth is associated with inci-
Abstract
Objective: To analyze the differences of maternal serum soluble en-
doglin level in preeclampsia, molar pregnancy, and normal preg-
nancy, and to analyze the correlation between maternal serum sol-
uble endoglin level with gestational age.
Method: This is a cross-sectional comparative analytic study involv-
ing 18 preeclampsia cases, 18 molar pregnancies, and 18 normal
pregnancies. The sample were obtained from Dr. Hasan Sadikin hos-
pital and six satellite hospitals from January until March 2013. The
comparison of mean seng serum level of the preeclampsia, molar
pregnancy, and normal pregnancy group was calculated using
Kruskal Wallis, and the correlation were calculated using Rank
Spearman.
Result: The mean level of seng serum in preeclampsia group was
higher (168.79 ng/ml) than in molar pregnancy (43.47 ng/ml) and
normal pregnancy (32.38 ng/ml). There is no significant difference
of serum seng level between molar and normal pregnancy, with p
value of 0.393 (p>0.05). There is significant differences of seng se-
rum level between preeclampsia group and molar pregnancy
(p=0.000), but no significant differences between molar and normal
pregnancy, p value=0.393 (p>0.05). There is positive correlation
between seng serum level of normal pregnancy with gestational age
(rs=0.647; p<0.001).
Conclusion: Maternal serum seng level in preeclampsia is higher
than the level of which in molar pregnancy and normal pregnancy.
[Indones J Obstet Gynecol 2014; 2: 76-81]
Keywords: molar pregnancy, normal pregnancy, preeclampsia, sol-
uble endoglin level
Abstrak
Tujuan: Menganalisis perbedaan kadar seng serum ibu antara ke-
hamilan preeklampsia, kehamilan mola dan kehamilan normal, serta
menganalisis korelasi antara kadar seng serum ibu dengan usia ke-
hamilan pada kehamilan preeklampsia, kehamilan mola dan hamil
normal.
Metode: Rancangan penelitian ini adalah uji potong silang terhadap
18 kasus preeklampsia, 18 kasus mola, dan 18 kehamilan normal yang
memenuhi kriteria inklusi, yang datang ke RS Dr. Hasan Sadikin dan
enam RS jejaring periode Januari-Maret 2013. Perbandingan rerata
kadar seng serum preeklampsia, kehamilan mola dan hamil normal
dihitung menggunakan uji Kruskal-Wallis, dan korelasi antara kadar
seng serum dengan usia kehamilan dihitung menggunakan uji kore-
lasi Rank Spearman.
Hasil: Rerata kadar seng pada preeklampsia lebih tinggi (168,79 ng/ml)
dibandingkan dengan kehamilan mola (43,47 ng/ml) dan hamil normal
(32,38 ng/ml). Terdapat perbedaan yang bermakna antara kadar seng
serum kehamilan preeklampsia dengan kehamilan mola dan hamil nor-
mal (p=0,000), namun tidak terdapat perbedaan kadar seng serum yang
bermakna antara kehamilan mola dengan kehamilan normal, nilai p =
0,393 (p>0,05). Uji korelasi memperlihatkan adanya korelasi positif an-
tara seng serum ibu kehamilan normal (rs=0,647; p<0,001) dengan usia
kehamilan, dan didapatkan korelasi negatif antara kadar seng kehami-
lan preeklampsia dan kehamilan mola, (rs=-0,064; p=0,908 dan -0,029;
p=0,908) dengan usia kehamilan.
Kesimpulan: Tampak kadar seng serum ibu pada kehamilan preek-
lampsia lebih tinggi dibandingkan kelompok kehamilan mola dan ke-
hamilan normal.
[Maj Obstet Ginekol Indones 2014; 2: 76-81]
Kata kunci: hamil normal, kehamilan mola, preeklampsia, soluble en-
doglin
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dences of hydatidiform mole and choriocarcino-
ma.2
Preeclampsia is still a main cause of maternal
and perinatal morbidity and mortality. Also, pree-
clampsia is often found in molar pregnancy. The
unclear etiology and pathophysiology of pree-
clampsia would affect in not optimal management
of the disorder. Meanwhile, various researchs have
been paying attention to theories of endothelial
damage as the pathogenesis of preeclampsia,
which is caused by disruption of angiogenesis. One
of the substances involved in this process is soluble
endoglin. This substance increases in endothelial
damage. Therefore, the measurement of its level
would show the extent of endothelial damage in
the early stage of preeclampsia. This substance has
been known to exert anti-angiogenic effect, thus
disrupting endothelial differentiation in blood ves-
sels.3
In molar pregnancy, the growth or proliferation
of trophoblastic cells is excessive. In a former study
about an anti-angiogenic factor sFlt-1 in molar
pregnancy, Kanter, et al. reported a significant in-
crease of protein sFlt-1 in molar pregnancy com-
pared to the normal pregnancy. The imbalance of
those anti-angiogenic factors is strongly believed
to trigger abnormal growth and migration of tro-
phoblasts.2,4,5
Soluble endoglin is a 65kDa truncated form of
endoglin which does not have any trans membrane
and domain cytoplasm. It is produced by placenta,
and known to be increased in maternal serum of
preeclamptic women. Seng inhibits the formation
of capillary tubes in vitro, while induces vascular
permeability and hypertension with focal glomeru-
lar endotheliosis in vivo. Therefore, endoglin and
seng seems promising as a marker of pregnancy
complications associated with inadequate placen-
tation.6
Hydatidiform mole and preeclampsia are two
disorders unique to pregnancy. Both have placental
dysfunctions which are integrated to the process
of each disease. Hydatidiform mole is a disorder in
genetic formation, characterized by various extent
of trophoblastic proliferation and hydrophic cha-
nge of chorionic villi.7
Evidences have supported the important role of
soluble endoglin in the pathophysiology of pree-
clampsia, upon its increased level in severe pree-
clampsia, early-onset preeclampsia, and fetal re-
striction.8 Because of this involvement, the protein
might be used as an early biomarker of preeclamp-
sia and molar pregnancy. The increased level of
soluble endoglin found in a case of partial mole
with preeclampsia might reflect an imbalance of
angiogenetic factor in molar pregnancy.5
METHOD
This is a cross-sectional comparative analytic study
involving groups of molar pregnancy with pree-
clampsia, and molar pregnancy with normal preg-
nancy. Subjects were pregnant women with normal
pregnancy, molar pregnancy, or preeclampsia,
which is examined in Dr. Hasan Sadikin Hospital
and its network hospitals (Cibabat Hospital, Ujung
Be-rung Hospital, Majalaya Hospital, Slamet Garut
Hospital, and Sumedang Hospital) within the study
period, who fulfilled the inclusion criteria. There
were 18 subjects in each group. From each subject,
5 cc of blood were withdrawn and measured for
soluble endoglin level in Prodia laboratory with
high sensitivity indirect sandwich Enzyme-Linked
Immunosorbent Assay (ELISA) using human endo-
glin immunoassay kit.
Serum endoglin levels as numerical data were
tested for normality with Kolmogorov-Smirnov/
Shaphiro Wilk test. Characteristics of the three
groups would be compared with Anova test if the
data were normally-distributed or non-parametric
Kruskal-Wallis test if they were not. Upon finding
of significant differences between the characteris-
tics, the groups would then be analyzed with Post
Hoc.
The difference of serum seng level between the
group of preeclampsia and normal pregnancy, pre-
eclampsia and molar pregnancy, and also molar
and normal pregnancy, were analyzed by Indepen-
dent T test if the data were normally-distributed,
or Mann-Whitney test if they were not. P value of
<0.05 reflects a significant result. SPSS version 18.0
for Windows was used in analyzing data.
Upon finding of significant difference of seng
level and characteristics in each group, data could
be further analyzed for correlation with Pearson
correlation test if they were normally distributed,
or Rank Spearman test if they were not. Then Guil-
ford Empirical Rules was used to analyze the cor-
relation strength of both variables.
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RESULT
During the study period, 54 subjects fulfilled inclu-
sion criteria, consisted of 18 subjects in each group
of normal pregnancy, severe preeclampsia, and
molar pregnancy. The characteristics such as ma-
ternal age, parity, and gestational age, were mat-
ched in order to be comparable.
Table 1 shows no significant difference of ma-
ternal age (p=0.730) and parity (p=0.249) between
the preeclampsia, molar pregnancy, and normal
pregnancy groups, while there is a significant dif-
ference of gestational age (p=0.000).
Kruskal-Wallis test shows that at least two
groups have significantly different level of serum
seng (p=0.000). Therefore, Post Hoc analysis would
be done to analyze which groups had a significant
difference of seng level.
Table 1. Comparative characteristics from the research group.
Characteristic
Group
p value
Normal pregnancy
(n=18)
Molar pregnancy
(n=18)
Preeclampsia
(n=18)
Maternal age (years old) 0.730*
• <20 0 3 1
• 20-24 5 1 5
• 25-29 4 6 3
• 30-35 9 8 9
• Mean (± SD) 27.67 (4.3) 28.33 (6.6) 28.44 (5.7)
Range 21-34 17-35 19-35
Parity 0.249**
• 0 9 5 7
• 1-3 9 11 11
• ≥ 4 0 2 0
• Mean (± SD) 1.50 (5.14) 1.83 (6.18) 1.61 (5.02)
Range 1-2 1-3 1-2
Gestational age (weeks) 0.000*
• < 20 6 14 0
• 20-28 8 4 5
• ≥ 29 4 0 13
• Mean (± SD) 22.22 (9.52) 17.33 (2.79) 31.61 (4.4)
Range 7-34 12-22 23-34
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Table 2 shows no significant difference of seng
level between normal pregnancy and molar preg-
nancy (p=0.393). While there is significant differ-
ence of serum seng level between molar pregnancy
and preeclampsia (p=0.000) and also normal preg-
nancy and preeclampsia (p=0.000). Seng level in
preeclampsia group is significantly higher than the
level of which in molar and normal pregnancy
groups.
Table 3 shows that Spearman correlation test in
95% confidence interval results in a significant cor-
relation between seng level and gestational age in
normal pregnancy group, with r value of 0.647
(p<0.001).
DISCUSSION
The characteristics compared in this study were
parity and gestational age, as they are anticipated
to be confounding in the incidence of preeclampsia
and molar pregnancy, and therefore the biggest
bias in this study.
This study shows that serum seng level of pree-
clamptic women is higher than those of molar and
normal pregnancy. Maternal serum seng level in
preeclampsia is significantly higher than the level
of which in normal pregnancy, with p value of
<0.05. This is consistent with the previous studies.
Levine, et al. reported an increase of seng level in
women with early-onset preeclampsia, higher than
control group (46.4 ng/ml vs 9.8 ng/ml, p<0.001).
Another study by Salahuddin, et al. Results in sig-
nificant increase of serum seng level in preeclamp-
tic women (69.2 ± 42.5 ng/ml) compared to the
control group (15.5 ± 6.9 ng/ml).
Endoglin is expressed in low level in normal en-
dothelium, while being very high in vascular endo-
thelium during embryogenesis, inflammatory tis-
sue and wound healing, vascular trauma, and vas-
cular tumor. Its expression is also found in some
cells in cardiovascular system.9-13
Soluble endoglin, the soluble form of endoglin
which circulates with blood, is produced by pla-
centa. The level of seng in circulation is found ele-
vated in the last two months of normal pregnancy
in a longitudinal study, while an increase in con-
centration is observed earlier in pregnancy with
recurrent preeclampsia.8,14
A case control study reported that concentration
of seng in circulation increases in preeclamptic
women. This elevation can be detected 2-3 months
before the clinical manifestations of preeclampsia
are observed. Meanwhile, sFlt-1, another antiangio-
genic factor, is detected 5 weeks before the clinical
onset. These allow seng to be an early marker of
preeclampsia.8,15,16 Thus, elevation of soluble en-
doglin level in normal pregnancy group may indi-
cate risk of preeclampsia in the previously normal
pregnancy.
On the other hand, another study found that in-
cidence of preeclampsia is higher when seng ele-
vation accompanies the elevation of other biomar-
kers, such as sFlt-1, VEGF, or PlGF. This needs to
be understood, as early-onset preeclampsia causes
neonatal morbidity and mortality due to iatrogenic
prematurity, whereas definitive treatment for pre-
eclampsia is still limited. Therefore, early detection
would be very beneficial in observing and optimali-
zation of the management.17,18
However, previous data shows that serum seng
starts to elevate as gestational age advances in nor-
mal pregnancy population.8,19 This is believed to
cause bias to the study, as the control serum sam-
ples were withdrawn not only from the early tri-
mester, but also the third trimester.
Table 2. Post Hoc analysis of maternal serum seng level
between three study groups.
Post Hoc Analysis of Seng Level (ng/ml) p value*
Normal pregnancy (32.38 ± 19.13) vs molar
pregnancy (43.47 ± 51.71)
0.393
Molar pregnancy (43.47 ± 51.71) vs pre-
eclampsia (168.79 ± 48.58)
0.000
Normal pregnancy (32.38 ± 19.13) vs pre-
eclampsia(168.79 ± 48.58)
0.000
Note: * Mann-Whitney test
Table 3. Correlation between seng level and gestational
age in normal pregnancy, molar pregnancy, and preeclamp-
sia.
Group
Correlation between Serum Endoglin
Level (ng/ml) and Gestational Age
rs p value
Normal pregnancy
(n=18) 0.647 <0.001
Molar pregnancy
(n=18) -0.029 0.908
Preeclampsia
(n=18) -0.064 0.800
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This study also shows a positive correlation bet-
ween serum seng level with gestational age in nor-
mal pregnancy. Unlike the other two groups how-
ever, in which the correlation does not exist. The
result is consistent with two previous studies
showing positive correlation between serum seng
level with the advancing gestational age in normal
pregnancy.8,18 It is, on the other hand, different
from a study by Vaisbuch, et al. which resulted in
no significant correlation between serum seng le-
vel with the advancing gestational age (Spearman
rho 0.3, p=0.06).20
Another study reported that beside gestational
age and history of chronic disease, tissue hypoxia
can also affect the expression of soluble endoglin.
It is proven by elevation soluble endoglin concen-
tration following hypoxic condition of human um-
bilical vein endothelial cells (HUVEC). This is con-
sistent with the pathophysiology of preeclampsia,
in which hypoxic condition is observed. Meanwhile,
elevation of seng level is also observed in molar
pregnancy, although it is still lower than the level
of which in preeclampsia, supporting the theory of
placental hypoperfusion in hydatidiform mole.
The data distribution shows some extreme point
in molar pregnancy group. Subject C10 have the
highest soluble endoglin level, far above those of
the other subjects’. The subject turns out to be a
partial mole case with manifestations of pree-
clampsia. This is consistent with the previous lite-
rature which states that there was an increase of
seng level in partial mole with preeclampsia as its
complication.2
This study had some data deviate quite far. This
can be explained by some improvement in the per-
formance of the test done on the sample, which is
probably different in its sensitivity. Therefore, the
test results differently although the previous stu-
dies were also using the same kit. Moreover, the
duration of sample storage can also affect the pro-
tein concentration measured.
CONCLUSION
There is a significant difference of serum soluble
endoglin level between preeclampsia and molar
pregnancy. The level is higher in preeclampsia than
it is in molar pregnancy. There is a positive corre-
lation between serum seng level and gestational
age in normal pregnancy.
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